Is It Possible that COVID-19 Boosters Trigger a Cancer Relapse? Insights from Dr. Dalgleish

COVID-19 boosters are used to activate the immune response by synthesizing antibodies against foreign pathogens, however, some adverse events have been associated with these boosters. In the aggregate via published case series alone, over two hundred cases of cancer or cancer relapse have been reported yesterday by TrialSite. Yet none of these cases can prove causation (the studies aren&rsquo;t designed for that), and the incidence remain rare given over 230 million people are considered fully vaccinated in America alone. Regardless, several cases of cancer relapse have been reported after the administration of COVID-19 boosters, according to Angus Dalgleish, a professor of oncology at&nbsp;St.George&rsquo;s University&nbsp;of London. During an interview, he raised his&nbsp;concerns&nbsp;about the COVID-19 boosters&rsquo; long-term consequences, perturbation of the immune system, and the development or relapse of aggressive cancers. TrialSite&nbsp;investigates&nbsp;the reports of cancer related to COVID-19 vaccination.
Dr. John Campbell, a retired British nurse and healthcare educator,&nbsp;interviewed&nbsp;Professor Dalgleish to discuss his insights into boosters, immunity, and cancer risk.&nbsp;The focus of Dalgleish&rsquo;s extensive research is immunotherapies and cancer vaccines. In this interview, he described his observations on patients suffering from melanoma.&nbsp;